Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 May 26.
Published in final edited form as: Curr Diab Rep. 2010 Oct;10(5):345–349. doi: 10.1007/s11892-010-0131-5

Infant and Childhood Diet and Type 1 Diabetes Risk: Recent Advances and Prospects

Jill M Norris 1
PMCID: PMC4443269  NIHMSID: NIHMS690030  PMID: 20640941

Abstract

Type 1 diabetes is a chronic autoimmune disease characterized by a preclinical period of autoimmunity. It is well accepted that both genetic and environmental factors contribute to disease risk. Given that type 1 diabetes, and its preclinical autoimmunity, appear early in life, infant and childhood diet have been implicated as potential initiating exposures in the etiology of the disease. Several publications in the past year have provided further evidence for existing hypotheses regarding the roles of wheat, cow’s milk, omega-3 fatty acids, and the maternal diet during pregnancy. However, inconsistencies in findings between studies suggest the need for collaboration and standardization of study methods to move forward in research in this area. One such example of this is the TEDDY (The Environmental Determinants of Diabetes in the Young) study, which is an international, multicenter birth cohort study with standardized recruitment, dietary collection methodologies, and analytic approaches.

Keywords: Infant diet, Childhood diet, Maternal diet, Autoimmunity, Type 1 diabetes, Omega-3 fatty acids, Wheat, Gluten, Microbiota, Cow’s milk, Intestinal permeability

Introduction

For decades, researchers have been actively investigating the role of infant and childhood diet in type 1 diabetes. Much of this work is comprehensively summarized in two review articles that were recently published [1, 2•]. Most of the recent focus has been on investigating the role of cow’s milk, wheat/cereals/gluten, omega-3 fatty acids, and vitamin D, as well as the overall role of the gut immune system. Papers published in the last year (2009–2010) further elucidate a number of these research areas, as reviewed below. Type 1 diabetes is an autoimmune disease characterized by the destruction of the insulin-producing β cells in the pancreatic islets. Islet autoimmunity precedes and is strongly predictive of type 1 diabetes development [3], and is therefore a useful intermediate end point when examining the role of environmental risk factors, such as diet. Therefore, this review includes research studies using type 1 diabetes or islet autoimmunity, where appropriate.

Cow’s Milk

Prospective studies of high-risk children show that autoimmunity can appear as early as the first year of life [4, 5], suggesting that the putative environmental factor must occur very early in life in many situations. Therefore, infant diet behaviors, including breast-feeding and age at first exposure to non–breast milk substitutes (eg. cow’s milk formula), are likely candidate exposures. Numerous studies have been conducted examining the association between age at introduction of cow’s milk and type 1 diabetes or islet autoimmunity, as reviewed in Knip et al. [2•], and they have been inconsistent. One meta-analysis of case–control studies [6] and a nested case–control study of a cohort study [7] suggest an increased risk; a second meta-analysis [8] and the majority of the prospective cohort studies show no association [913]. Although there can be several explanations for this inconsistency, including methodologic differences in population selection and data collection, one alternative explanation is gene-environment interaction, with differences in the observed exposure association driven by differences in gene allele frequency across populations. Lempainen et al. [14] genotyped polymorphisms in three type 1 diabetes candidate genes (INS, PTPN22, and CTLA4) and tested whether their effect on risk of islet autoimmunity differed by whether children had been exposed to cow’s milk formula before or after 6 months of age. The investigators found that the association between PTPN22 and islet autoimmunity was only significant in children exposed to cow’s milk formula prior to 6 months of age, suggesting that the effect of certain environmental exposures, such as early exposure to milk, may not be involved in the disease process in all cases, and that this gene-environment interaction may explain the contradictory observations on this topic across different populations.

Virtanen et al. [15] set out to investigate whether serum fatty acids differed between children developing islet autoimmunity and those remaining autoantibody negative. Myristic acid, pentadecanoic acid, monounsaturated palmitoleic acid isomers 16:1 n-7 and 16:1 n-9, and conjugated linoleic acid were positively associated with the risk of islet autoimmunity at or before the time of seroconversion. Because these serum fatty acids are biomarkers of milk and ruminant meat fat consumption [16, 17], this suggests that higher current consumption of milk and meat may be associated with risk of islet autoimmunity. Linoleic acid, which reflects vegetable oil intake [18], was inversely associated with the risk of islet autoimmunity, suggesting that current consumption of vegetable oil may be protective.

Maternal Diet during Pregnancy

Two papers published in the past year investigated dietary exposures in the maternal diet during pregnancy and risk of islet autoimmunity. Brekke and Ludvigsson [19] used a 22-item food frequency questionnaire collected just after delivery to examine the maternal diet collected from 5724 mother-infant pairs in Sweden. The investigators found that a low consumption of vegetables (<1 time/week) in the maternal diet was associated with a higher risk of islet autoimmunity in the child compared with daily consumption of vegetables (OR, 2.89; 95% CI, 1.18–7.05). No other factors in the maternal diet were found to be associated with islet autoimmunity in this analysis, which is contradictory to previous studies that have suggested that greater consumption of potatoes was associated with a lower risk of islet autoimmunity in children at increased risk for type 1 diabetes [20].

A Finnish study examined the maternal diet during pregnancy in 4297 mothers whose children are at increased risk for type 1 diabetes, recently reporting data concerning vitamin D intake [21]. Using an 181-item food frequency questionnaire, which asked about intake during the 8th month of pregnancy and was collected 1 to 3 months after delivery, the investigators found that vitamin D intake was not associated with risk of islet autoimmunity nor type 1 diabetes in the child, which contradicts previous studies that found that maternal vitamin D intake was associated with a decreased risk of islet autoimmunity in the child overall [22] or in the first year of life [23].

Wheat

In the biobreeding diabetes-prone (BB-DP) rat, it has been shown that gluten precipitates the onset of autoimmunity and diabetes [24]. Moreover, MacFarlane et al. [25] identified a wheat storage protein, which was subsequently identified as Glo-3A that may be associated with islet damage, by observing that antibodies to this protein were detectable in patients with diabetes but not in nondiabetic patients. Two prospective studies of high-risk infants and children showed an increased risk for islet autoimmunity associated with first introduction of cereals or gluten in the first 3 months of life when compared with first introduction in the 4th to 6th month of life [9, 10]. These data suggest that there are specific times in infancy wherein gluten or cereal exposure is associated with an increased risk of developing islet autoimmunity. The risk associated with early exposure may suggest a mechanism involving an aberrant immune response to cereal, gluten, or wheat antigens in an immature gut immune system among susceptible individuals.

Two studies were published in the past year that investigated what the aberrant immune response to wheat might be. Simpson et al. [26] compared levels of antibodies to a wheat storage globulin homologue of Glo-3A, which is a nongluten component of the wheat protein matrix, in children with and without islet autoimmunity. Although Glo-3A antibody levels did not differ between children with and without islet autoimmunity, the Glo-3A antibody levels were correlated with gluten intake, and inversely correlated with breast-feeding duration, but only in the children who developed islet autoimmunity. This suggests that Glo-3A antibodies may be markers of dietary exposure and may represent a unique response to exposure that is specific to children developing autoimmunity.

Mojibian et al. [27•] compared the immune response to wheat polypeptides between patients with type 1 diabetes and healthy control subjects. Diabetic patients showed a marked T-cell proliferation response to wheat polypeptides and, to a lesser extent, other dietary antigens such as ovalbumin and gliadin. These data suggest a general impairment of oral tolerance in some diabetic patients with the strongest response induced by a mixture of wheat polypeptides. One potential mechanism is that wheat polypeptides or perhaps gliadin (the fraction of gluten that is the most antigenic) pass through the gut epithelial barrier of the intestine, possibly during an episode of increased intestinal permeability for some as yet unknown reason. In susceptible individuals, this then triggers an immune response that leads to an inflammatory reaction, and then eventually autoimmune disease. Additional work needs to be done to provide evidence for this hypothesis; nonetheless, these two recently published papers as well as previous work suggest that the gut is an active player in the disease process leading to diabetes.

Gut Microbiome/Gut Permeability/Mucosal Immunity

In 2008, Vaarala et al. [28••] published a review of the evidence that type 1 diabetes results from a complex interrelationship between the gut microbiome, gut permeability, and mucosal immunity. Although there are no studies showing that animals or humans with type 1 diabetes or at risk for diabetes have a different microbiome than nondiabetic individuals, a study in nonobese diabetic mice showing that probiotic administration prevented the development of diabetes is suggestive that the microbiome might be important [29]. A study published this year adds evidence to this hypothesis. Valladares et al. [30] isolated two Lactobacillus strains from BB diabetes-resistant (BB-DR) rats, and then injected them into BB-DP rats to investigate their effect on the development of diabetes. BB-DR rats given Lactobacillus johnsonii but not Lactobacillus reuteri post-weaning developed diabetes at a reduced rate. These rats showed higher levels of the tight junction protein, claudin, suggesting that the feeding of L. johnsonii may have increased the gut barrier, thus inhibiting the passage of inflammatory antigens. This hypothesis is supported by a number of animal and human studies suggesting that the gut is more permeable in type 1 diabetic patients and that this may be true even before the diagnosis of type 1 diabetes [28••]. And finally, observations that dietary exposures, particularly during infancy, can modulate the gut microbiota [31, 32] suggest one mechanism by which diet may have an important role in the etiology of type 1 diabetes.

Omega-3 Fatty Acids

Factors in the diet may also play a protective role in the etiology of type 1 diabetes. In a longitudinal observational study following otherwise healthy children who are at increased risk for developing type 1 diabetes, investigators reported that higher omega-3 fatty acid intake was associated with a lower risk of islet autoimmunity (hazard ratio [HR], 0.45), and likewise, that higher omega-3 fatty acid levels in the erythrocyte membrane were associated with a lower risk of islet autoimmunity (HR, 0.63) [33]. This finding is supported by a case–control study from Norway that showed that children with type 1 diabetes were less likely to have been given cod liver oil during infancy than controls [34]. A paper published in the past year sheds light on the possible mechanism behind these observations. Wei et al. [35•] developed a transgenic mouse model that overexpressed the mfat-1 gene, which converts omega-6 fatty acids to omega-3 fatty acids, with the end result being higher endogenous production of omega-3 fatty acids. This enabled the investigators to examine the effect of higher omega-3 fatty acid levels on the insulin-producing β cells of the pancreas. They showed that higher cellular production of omega-3 fatty acids enhances insulin secretion and confers resistance to cytokine-induced β-cell destruction [35•]. At the moment, it is unclear how changes in polyunsaturated fatty acid levels impact insulin secretion and survival of the β cells. The production of omega-3 fatty acids in the β cells and islets via mfat-1 activity is achieved by using omega-6 fatty acids as substrates, thus bringing down the ratios of omega-6 to omega-3 fatty acids. Because the eicosanoid products derived from omega-6 fatty acids are more proinflammatory than those derived from omega-3 fatty acids, this would reduce the inflammatory state in the β cell, and may explain mechanistically why increased intake of omega-3 fatty acids or a decreased ratio of omega-6 to omega-3 fatty acids may reduce the risk of type 1 diabetes.

Prospects: The Environmental Determinants of Diabetes in the Young (TEDDY)

Although quite a bit of interesting research regarding diet and risk of type 1 diabetes has been published in the past year, there are still a number of holes and a troubling lack of consistency in the findings to date. It is likely that the results from previous studies have been confounded by imprecise assessment of dietary exposure, recall bias, failure to assess dietary exposures at very early ages, differing definitions of exposures, and small sample sizes. While many of these issues will be worked out with time as the scientific process takes place, an impressive development that is likely to facilitate this area of research in the near future is the collaborative study, TEDDY (The Environmental Determinants of Diabetes in the Young). The TEDDY study is a multicenter, multinational, epidemiologic study aimed at identifying environmental exposures that are associated with increased risk of autoimmunity and type 1 diabetes [36]. Maternal diet during pregnancy is assessed with a short food frequency questionnaire, concentrating on the intakes of fish, milk, and cereals. The duration of total and exclusive breast-feeding, age at introduction of various foods during the first 2 years of life, type of infant formulas used, source of drinking water (eg, local waterworks, bottled water, and private wells), elimination diets, and use of dietary supplements are recorded prospectively. Infant and childhood diet are assessed by 3-day diet records at 3-month intervals during the first year of life and biannually thereafter. In addition, plasma, erythrocytes, and toenail clippings are stored for future dietary biomarker analyses. TEDDY will provide an opportunity to fill important gaps in our understanding of the role of diet in the etiology of type 1 diabetes by studying from birth over 7000 high-risk children using an extensive arsenal of prospective dietary exposure assessments.

Conclusions

Evidence is building that infant and childhood diet play an important role in the etiology of type 1 diabetes and diabetes autoimmunity, and recent studies have started to explore the mechanism behind this relationship. Newly formed collaborative studies will help us to elucidate and interpret these exciting findings.

Footnotes

Disclosure No potential conflict of interest relevant to this article was reported.

References

Papers of particular interest, published recently, have been highlighted as:

• Of importance

•• Of major importance

  • 1.Virtanen SM, Knip M. Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age. Am J Clin Nutr. 2003;78:1053–1067. doi: 10.1093/ajcn/78.6.1053. [DOI] [PubMed] [Google Scholar]
  • 2•.Knip M, Virtanen SM, Akerblom H. Infant feeding and risk of type 1 diabetes. Am J Clin Nutr. 2010;91:1506S–1513S. doi: 10.3945/ajcn.2010.28701C. This article reviews the latest research in the area of infant diet and risk of type 1 diabetes and islet autoimmunity. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Verge CF, Gianani R, Kawasaki E, et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes. 1996;45:926–933. doi: 10.2337/diab.45.7.926. [DOI] [PubMed] [Google Scholar]
  • 4.Ziegler AG, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes. 1999;48:460–468. doi: 10.2337/diabetes.48.3.460. [DOI] [PubMed] [Google Scholar]
  • 5.Kimpimaki T, Kupila A, Hamalainen AM, et al. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study. J Clin Endocrinol Metab. 2001;86:4782–4788. doi: 10.1210/jcem.86.10.7907. [DOI] [PubMed] [Google Scholar]
  • 6.Gerstein HC. Cow's milk exposure and type I diabetes mellitus - a critical overview of the clinical literature. Diabetes Care. 1994;17:13–19. doi: 10.2337/diacare.17.1.13. [DOI] [PubMed] [Google Scholar]
  • 7.Kimpimaki T, Erkkola M, Korhonen S, et al. Short-term exclusive breastfeeding predisposes young children with increased genetic risk of Type I diabetes to progressive beta-cell autoimmunity. Diabetologia. 2001;44:63–69. doi: 10.1007/s001250051581. [DOI] [PubMed] [Google Scholar]
  • 8.Norris JM, Scott FW. A meta-analysis of infant diet and insulin-dependent diabetes mellitus: do biases play a role? Epidemiology. 1996;7:87–92. doi: 10.1097/00001648-199601000-00015. [DOI] [PubMed] [Google Scholar]
  • 9.Norris JM, Barriga K, Klingensmith G, et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA. 2003;290:1713–1720. doi: 10.1001/jama.290.13.1713. [DOI] [PubMed] [Google Scholar]
  • 10.Ziegler AG, Schmid S, Huber D, et al. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA. 2003;290:1721–1728. doi: 10.1001/jama.290.13.1721. [DOI] [PubMed] [Google Scholar]
  • 11.Virtanen SM, Kenward MG, Erkkola M, et al. Age at introduction of new foods and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes. Diabetologia. 2006;49:1512–1521. doi: 10.1007/s00125-006-0236-1. [DOI] [PubMed] [Google Scholar]
  • 12.Couper JJ, Steele C, Beresford S, et al. Lack of association between duration of breast-feeding or introduction of cow's milk and development of islet autoimmunity. Diabetes. 1999;48:2145–2149. doi: 10.2337/diabetes.48.11.2145. [DOI] [PubMed] [Google Scholar]
  • 13.Savilahti E, Saarinen KM. Early infant feeding and type 1 diabetes. Eur J Nutr. 2009;48:243–249. doi: 10.1007/s00394-009-0008-z. [DOI] [PubMed] [Google Scholar]
  • 14.Lempainen J, Vaarala O, Makela M, et al. Interplay between PTPN22 C1858T polymorphism and cow's milk formula exposure in type 1 diabetes. J Autoimmun. 2009;33:155–164. doi: 10.1016/j.jaut.2009.04.003. [DOI] [PubMed] [Google Scholar]
  • 15.Virtanen SM, Niinisto S, Nevalainen J, et al. Serum fatty acids and risk of advanced [beta]-cell autoimmunity: a nested case-control study among children with HLA-conferred susceptibility to type I diabetes. Eur J Clin Nutr. 2010 May 26; doi: 10.1038/ejcn.2010.75. [Epub ahead of print] [DOI] [PubMed] [Google Scholar]
  • 16.Wolk A, Furuheim M, Vessby B. Fatty acid composition of adipose tissue and serum lipids are valid biological markers of dairy fat intake in men. J Nutr. 2001;131:828–833. doi: 10.1093/jn/131.3.828. [DOI] [PubMed] [Google Scholar]
  • 17.Crowe FL, Skeaff CM, Green TJ, Gray AR. Serum fatty acids as biomarkers of fat intake predict serum cholesterol concentrations in a population-based survey of New Zealand adolescents and adults. Am J Clin Nutr. 2006;83:887–894. doi: 10.1093/ajcn/83.4.887. [DOI] [PubMed] [Google Scholar]
  • 18.Zock PL, Mensink RP, Harryvan J, et al. Fatty acids in serum cholesteryl esters as quantitative biomarkers of dietary intake in humans. Am J Epidemiol. 1997;145:1114–1122. doi: 10.1093/oxfordjournals.aje.a009074. [DOI] [PubMed] [Google Scholar]
  • 19.Brekke HK, Ludvigsson J. Daily vegetable intake during pregnancy negatively associated to islet autoimmunity in the offspring—The ABIS Study. Pediatr Diabetes. 2009 Sep 16; doi: 10.1111/j.1399-5448.2009.00563.x. [Epub ahead of print] [DOI] [PubMed] [Google Scholar]
  • 20.Lamb MM, Myers MA, Barriga K, et al. Maternal diet during pregnancy and islet autoimmunity in offspring. Pediatr Diabetes. 2008;9:135–141. doi: 10.1111/j.1399-5448.2007.00311.x. [DOI] [PubMed] [Google Scholar]
  • 21.Marjamaki L, Niinisto S, Kenward MG, et al. Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia. 2010;53:1599–1607. doi: 10.1007/s00125-010-1734-8. [DOI] [PubMed] [Google Scholar]
  • 22.Fronczak CM, Baron AE, Chase HP, et al. In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care. 2003;26:3237–3242. doi: 10.2337/diacare.26.12.3237. [DOI] [PubMed] [Google Scholar]
  • 23.Brekke HK, Ludvigsson J. Vitamin D supplementation and diabetes-related autoimmunity in the ABIS study. Pediatr Diabetes. 2007;8:11–14. doi: 10.1111/j.1399-5448.2006.00223.x. [DOI] [PubMed] [Google Scholar]
  • 24.Scott FW, Rowsell P, Wang GS, et al. Oral exposure to diabetes-promoting food or immunomodulators in neonates alters gut cytokines and diabetes. Diabetes. 2002;51:73–78. doi: 10.2337/diabetes.51.1.73. [DOI] [PubMed] [Google Scholar]
  • 25.MacFarlane AJ, Burghardt KM, Kelly J, et al. A type 1 diabetes-related protein from wheat (Triticum aestivum). cDNA clone of a wheat storage globulin, Glb1, linked to islet damage. J Biol Chem. 2003;278:54–63. doi: 10.1074/jbc.M210636200. [DOI] [PubMed] [Google Scholar]
  • 26.Simpson M, Mojibian M, Barriga K, et al. An exploration of Glo-3A antibody levels in children at increased risk for type 1 diabetes mellitus. Pediatr Diabetes. 2009;10:563–572. doi: 10.1111/j.1399-5448.2009.00541.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27•.Mojibian M, Chakir H, Lefebvre DE, et al. Diabetes-specific HLA-DR-Restricted proinflammatory T-cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes. Diabetes. 2009;58:1789–1796. doi: 10.2337/db08-1579. This article investigates the characteristics of the immune response to wheat and other antigens and how this may differ in people with and without type 1 diabetes. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28••.Vaarala O, Atkinson MA, Neu J. The “perfect storm” for type 1 diabetes. The complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes. 2008;57:2555–2562. doi: 10.2337/db08-0331. This is a comprehensive review of the role of the gut microbiome and mucosal immunity and how this may be related to type 1 diabetes risk. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Calcinaro F, Dionisi S, Marinaro M, et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia. 2005;48:1565–1575. doi: 10.1007/s00125-005-1831-2. [DOI] [PubMed] [Google Scholar]
  • 30.Valladares R, Sankar D, Li N, et al. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes to BB-DP rats. PLoS One. 2010;5:e10507. doi: 10.1371/journal.pone.0010507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Penders J, Thijs C, Vink C, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006;118:511–521. doi: 10.1542/peds.2005-2824. [DOI] [PubMed] [Google Scholar]
  • 32.Hansen AK, Ling F, Kaas A, et al. Diabetes preventive gluten-free diet decreases the number of caecal bacteria in non-obese diabetic mice. Diabetes Metab Res Rev. 2006;22:220–225. doi: 10.1002/dmrr.609. [DOI] [PubMed] [Google Scholar]
  • 33.Norris JM, Yin X, Lamb MM, et al. Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA. 2007;298:1420–1428. doi: 10.1001/jama.298.12.1420. [DOI] [PubMed] [Google Scholar]
  • 34.Stene LC, Joner G. The Norwegian Childhood Diabetes Study Group: Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am J Clin Nutr. 2003;78:1128–1134. doi: 10.1093/ajcn/78.6.1128. [DOI] [PubMed] [Google Scholar]
  • 35•.Wei D, Li J, Shen M, et al. Cellular production of n-3 PUFAs and reduction of n-6-to-n3 ratios in the pancreatic beta-cells and islets enhance insulin secretion and confer protection against cytokine-induced cell death. Diabetes. 2010;59:471–478. doi: 10.2337/db09-0284. This is an elegant investigation of the effect of increased omega-3 fatty acids and relative decrease in omega-6 fatty acids on the β cell of the pancreas. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.TEDDY Study Group The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Ann N Y Acad Sci. 2008;1150:1–13. doi: 10.1196/annals.1447.062. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES